CoChat

Tryptophan metabolism in health and disease- implications for non-communicable diseases

Gabela, Andiswa Msizi, Mthembu, Nontobeko, Hadebe, Sabelo · 2026 · Immunology Letters
Cited by 32

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.imlet.2025.107093

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 120

  1. Strasser, 2016, Mood, food, and cognition: role of tryptophan and serotonin, Curr. Opin. Clin. Nutr. Metab. Care, 19, 55
  2. Savitz, 2020, The kynurenine pathway: a finger in every pie, Mol. Psychiatry, 25, 131, 10.1038/s41380-019-0414-4 · DOI · Paper page
  3. Xue, 2023, Tryptophan metabolism in health and disease, Cell Metab., 35, 1304, 10.1016/j.cmet.2023.06.004 · DOI · Paper page
  4. Zou, 2015, Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation, Front. Biosci., 20, 4363, 10.2741/4363 · DOI · Paper page
  5. Seo, 2023, Immune regulation through tryptophan metabolism, Exp. Mol. Med., 55, 1371, 10.1038/s12276-023-01028-7 · DOI · Paper page
  6. O’Mahony, 2015, Serotonin, tryptophan metabolism and the brain-gut-microbiome axis, Behav. Brain Res., 277, 32, 10.1016/j.bbr.2014.07.027 · DOI · Paper page
  7. Park, 2021, A systems biology approach to investigating the interaction between serotonin synthesis by tryptophan hydroxylase and the metabolic homeostasis, Int. J. Mol. Sci., 22, 2452, 10.3390/ijms22052452 · DOI
  8. Haq, 2021, Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation, FASEB J., 35, 10.1096/fj.202100702R · DOI
  9. Höglund, 2019, Tryptophan metabolic pathways and brain serotonergic activity: a comparative review, Front. Endocrinol., 10, 10.3389/fendo.2019.00158 · DOI · Paper page
  10. Mohammad-Zadeh, 2008, Serotonin: a review, J. Vet. Pharmacol. Ther., 31, 187, 10.1111/j.1365-2885.2008.00944.x · DOI · Paper page
  11. Fiore, 2021, Tryptophan and indole metabolism in immune regulation, Curr. Opin. Immunol., 70, 7, 10.1016/j.coi.2020.12.001 · DOI · Paper page
  12. Zelante, 2013, Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22, Immunity, 39, 372, 10.1016/j.immuni.2013.08.003 · DOI · Paper page
  13. Lamas, 2018, Aryl hydrocarbon receptor and intestinal immunity, Mucosal. Immunol., 11, 1024, 10.1038/s41385-018-0019-2 · DOI · Paper page
  14. Wlodarska, 2017, Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation, Cell Host. Microbe, 22, 25, 10.1016/j.chom.2017.06.007 · DOI · Paper page
  15. Carbonnelle-Puscian, 2009, The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages, Leukemia, 23, 952, 10.1038/leu.2008.380 · DOI
  16. Boulland, 2007, Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation, Blood, 110, 220, 10.1182/blood-2006-07-036210 · DOI · Paper page
  17. Yue, 2015, IL4I1 is a novel regulator of M2 macrophage polarization that can inhibit t cell activation via l-tryptophan and arginine depletion and IL-10 production, PLoS One, 10, 10.1371/journal.pone.0142979 · DOI
  18. Boulland, 2007, Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation, Blood, 110, 220, 10.1182/blood-2006-07-036210 · DOI · Paper page
  19. Ye, 2020, Mucosal-associated invariant T cells restrict allergic airway inflammation, J. Allergy Clin. Immunol., 145, 1469, 10.1016/j.jaci.2019.12.891 · DOI
  20. Scarlata, 2015, Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ treg cells, Eur. J. Immunol., 45, 474, 10.1002/eji.201444897 · DOI
  21. Cousin, 2015, The immunosuppressive enzyme IL4I1 promotes FoxP3+ regulatory T lymphocyte differentiation, Eur. J. Immunol., 45, 1772, 10.1002/eji.201445000 · DOI
  22. Bod, 2018, IL-4–Induced gene 1: a negative immune checkpoint controlling B cell differentiation and activation, J. Immunol., 200, 1027, 10.4049/jimmunol.1601609 · DOI
  23. Puiffe, 2013, Antibacterial properties of the mammalian l-amino acid oxidase IL4I1, PLoS One, 8, 2, 10.1371/journal.pone.0054589 · DOI
  24. Presset, 2020, Identification of inhibitors of the immunosuppressive enzyme IL4I1, Bioorg. Chem., 94, 10.1016/j.bioorg.2019.103463 · doi:10.1016/j.bioorg.2019.103463
  25. Sadik, 2020, IL4I1 Is a metabolic immune checkpoint that activates the AHR and promotes tumor progression, Cell, 182, 1252, 10.1016/j.cell.2020.07.038 · DOI · Paper page
  26. Romagnani, 2016, IL4I1: key immunoregulator at a crossroads of divergent T-cell functions, Eur. J. Immunol., 46, 2302, 10.1002/eji.201646617 · DOI
  27. Zeitler, 2021, Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism, Elife, 10, 1, 10.7554/eLife.64806 · DOI
  28. Sadik, 2020, IL4I1 Is a metabolic immune checkpoint that activates the AHR and promotes tumor progression, Cell, 182, 1252, 10.1016/j.cell.2020.07.038 · DOI · Paper page
  29. Rannug, 2022, 6-Formylindolo[3,2-b]carbazole, a potent ligand for the aryl hydrocarbon receptor produced both endogenously and by microorganisms, can either promote or restrain inflammatory responses, Front. Toxicol., 4
  30. Zeitler, 2023, IL4i1 and IDO1: oxidases that control a tryptophan metabolic nexus in cancer, J. Biol. Chem., 299, 10.1016/j.jbc.2023.104827 · DOI
  31. Agus, 2018, Gut microbiota regulation of tryptophan metabolism in health and disease, Cell Host. Microbe, 23, 716, 10.1016/j.chom.2018.05.003 · DOI · Paper page
  32. Perdijk, 2024, Antibiotic-driven dysbiosis in early life disrupts indole-3-propionic acid production and exacerbates allergic airway inflammation in adulthood, Immunity, 10.1016/j.immuni.2024.06.010 · DOI
  33. Michaudel, 2020, Ozone-induced aryl hydrocarbon receptor activation controls lung inflammation via interleukin-22 modulation, Front. Immunol., 11
  34. D. Tang, L. Yue, R. Yao, L. Zhou, Y. Yang, L. Lu, W. Gao, P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer, 2017. www.impactjournals.com/oncotarget. · DOI
  35. Wang, 2024, Gut microbiota-derived tryptophan metabolites alleviate allergic asthma inflammation in ovalbumin-induced mice, Foods, 13
  36. Larabi, 2023, Bile acids as modulators of gut microbiota composition and function, Gut Microbes, 15, 10.1080/19490976.2023.2172671 · DOI · Paper page
  37. Wheeler, 2013, Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during Influenza Virus infection, J. Immunol., 190, 659, 10.4049/jimmunol.1201341 · DOI · Paper page
  38. Zhang, 2024, Metabolomics identifies phenotypic biomarkers of amino acid metabolism in milk allergy and sensitized tolerance, J. Allergy Clin. Immunol., 154, 157, 10.1016/j.jaci.2024.02.023 · DOI
  39. Miao, 2024, Impaired tryptophan metabolism by type 2 inflammation in epithelium worsening asthma, iScience, 27, 10.1016/j.isci.2024.109923 · DOI
  40. Paveglio, 2011, Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure, Am. J. Respir. Cell Mol. Biol., 44, 11, 10.1165/rcmb.2009-0167OC · DOI
  41. Ruan, 2025, The tryptophan metabolite 3-hydroxyanthranilic acid alleviates hyperoxia-induced bronchopulmonary dysplasia via inhibiting ferroptosis, Redox. Biol., 82, 10.1016/j.redox.2025.103579 · DOI
  42. Cervantes-Barragan, 2017, Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells, Science, 357, 806, 10.1126/science.aah5825 · DOI · Paper page
  43. Yano, 2015, Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis, Cell, 161, 264, 10.1016/j.cell.2015.02.047 · DOI · Paper page
  44. Psachoulia, 2016, IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation, Brain, 139, 3121, 10.1093/brain/aww254 · DOI · Paper page
  45. Suárez-Fariñas, 2013, Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis, J. Allergy Clin. Immunol., 132, 361, 10.1016/j.jaci.2013.04.046 · DOI · Paper page
  46. Czarnowicki, 2019, Atopic dermatitis endotypes and implications for targeted therapeutics, J. Allergy Clin. Immunol., 143, 1, 10.1016/j.jaci.2018.10.032 · DOI · Paper page
  47. Yu, 2019, A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor, J. Allergy Clin. Immunol., 143, 2108, 10.1016/j.jaci.2018.11.036 · DOI · Paper page
  48. Kyoreva, 2021, CYP1A1 enzymatic activity influences skin inflammation via regulation of the AHR pathway, J. Investig. Dermatol., 141, 1553, 10.1016/j.jid.2020.11.024 · DOI
  49. Musso, 1994, Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes, Blood, 83, 1408, 10.1182/blood.V83.5.1408.1408 · DOI
  50. Huang, 2023, Tryptophan, an important link in regulating the complex network of skin immunology response in atopic dermatitis, Front. Immunol., 14
  51. Castro-Portuguez, 2020, Kynurenine pathway, NAD+ synthesis, and mitochondrial function: targeting tryptophan metabolism to promote longevity and healthspan, Exp. Gerontol., 132, 10.1016/j.exger.2020.110841 · DOI · Paper page
  52. Xu, 2022, Metabolic rewiring of kynurenine pathway during hepatic ischemia-reperfusion injury exacerbates liver damage by impairing NAD homeostasis, Adv. Sci., 9, 10.1002/advs.202204697 · DOI
  53. Ito, 2003, Tryptophan metabolism was accelerated by exercise in rat, Adv. Exp. Med. Biol., 527, 531, 10.1007/978-1-4615-0135-0_61 · DOI
  54. Dehhaghi, 2022, The role of kynurenine pathway and NAD+ metabolism in myalgic encephalomyelitis/chronic fatigue syndrome, Aging Dis., 13, 698, 10.14336/AD.2021.0824 · DOI
  55. Newman, 2021, Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells, Mol. Cell, 81, 2290, 10.1016/j.molcel.2021.03.019 · DOI
  56. Conejos, 2021, Supplementing with l-tryptophan increases medium protein and alters expression of genes and proteins involved in milk protein synthesis and energy metabolism in bovine mammary cells, Int. J. Mol. Sci., 22, 1, 10.3390/ijms22052751 · DOI
  57. Xue, 2023, Tryptophan metabolism in health and disease, Cell Metab., 35, 1304, 10.1016/j.cmet.2023.06.004 · DOI · Paper page
  58. Hernandez, 2024, Sex differences in branched-chain amino acid and tryptophan metabolism and pathogenesis of youth-onset type 2 diabetes, J. Clin. Endocrinol. Metab., 109, e1345, 10.1210/clinem/dgad708 · DOI
  59. Cussotto, 2020, Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation, Front. Immunol., 11, 2020, 10.3389/fimmu.2020.00557 · DOI · Paper page
  60. Tuomainen, 2018, Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals, Nutr. Diabetes, 8, 35, 10.1038/s41387-018-0046-9 · DOI · Paper page
  61. Hu, 2022, Update of indoles: promising molecules for ameliorating metabolic diseases, Biomed. Pharmacother., 150, 10.1016/j.biopha.2022.112957 · DOI
  62. Zhang, 2024, Anti-adipogenesis effect of indole-3-acrylic acid on human preadipocytes and HFD-induced zebrafish, Acta Diabetol., 61, 975, 10.1007/s00592-024-02256-7 · DOI
  63. Wang, 2024, Heterogeneously elevated branched-chain/aromatic amino acids among new-onset type-2 diabetes mellitus patients are potentially skewed diabetes predictors, World J. Diabetes, 15, 53, 10.4239/wjd.v15.i1.53 · DOI
  64. M. Simonato, S. Dall’Acqua, C. Zilli, S. Sut, R. Tenconi, N. Gallo, P. Sfriso, L. Sartori, F. Cavallin, U. Fiocco, P. Cogo, P. Agostinis, A. Aldovini, D. Bruttomesso, R. Marcolongo, S. Comai, A. Baritussio, Tryptophan metabolites, cytokines, and fatty acid binding protein 2 in myalgic encephalomyelitis/chronic fatigue syndrome, Biomedicines 9 (2021) 1724. https://doi.org/10.3390/biomedicines9111724. · DOI
  65. Taenzer, 2023, Urine metabolite analysis to identify pathomechanisms of long COVID: a pilot study, Int. J. Tryptophan Res., 16, 10.1177/11786469231220781 · DOI
  66. Kashi, 2019, The IDO metabolic trap hypothesis for the etiology of ME/CFS, Diagnostics, 9, 82, 10.3390/diagnostics9030082 · DOI
  67. Kavyani, 2024, Dysregulation of the kynurenine pathway, cytokine expression pattern, and proteomics profile link to symptomology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Mol. Neurobiol., 61, 3771, 10.1007/s12035-023-03784-z · DOI
  68. Brown, 2020, Intestinal dysbiosis and tryptophan metabolism in autoimmunity, Front. Immunol., 11, 1741, 10.3389/fimmu.2020.01741 · DOI
  69. Criado, 2009, Indoleamine 2,3 dioxygenase–mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis, Arthritis Rheum., 60, 1342, 10.1002/art.24446 · DOI · Paper page
  70. Sofia, 2018, Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis, Inflamm. Bowel Dis., 24, 1471, 10.1093/ibd/izy103 · DOI · Paper page
  71. Nikolaus, 2017, Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases, Gastroenterology, 153, 1504, 10.1053/j.gastro.2017.08.028 · DOI · Paper page
  72. Nikolaus, 2017, Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases, Gastroenterology, 153, 1504, 10.1053/j.gastro.2017.08.028 · DOI · Paper page
  73. Metghalchi, 2015, Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production, Cell Metab., 22, 460, 10.1016/j.cmet.2015.07.004 · DOI
  74. Ghia, 2009, Serotonin has a key role in pathogenesis of experimental colitis, Gastroenterology, 137, 1649, 10.1053/j.gastro.2009.08.041 · DOI · Paper page
  75. Reigstad, 2015, Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells, FASEB J., 29, 1395, 10.1096/fj.14-259598 · DOI · Paper page
  76. Lamas, 2016, CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, Nat. Med., 22, 598, 10.1038/nm.4102 · DOI · Paper page
  77. Pongratz, 2019, Tryptophan metabolism in rheumatoid arthritis is associated with rheumatoid factor and predicts joint pathology evaluated by the Rheumatoid Arthritis MRI Score (RAMRIS), Clin. Exp. Rheumatol., 37, 450
  78. Moulin, 2023, Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis, Ann. Rheum. Dis., 83, 312, 10.1136/ard-2023-224014 · DOI
  79. Merlo, 2020, Differential roles of IDO1 and IDO2 in T and B cell inflammatory immune responses, Front. Immunol., 11, 2020, 10.3389/fimmu.2020.01861 · DOI
  80. Scott, 2009, The immunoregulatory enzyme IDO paradoxically drives B cell-mediated Autoimmunity1, J. Immunol., 182, 7509, 10.4049/jimmunol.0804328 · DOI
  81. Seymour, 2024, Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice, J. Clin. Investig., 134, 10.1172/JCI167671 · DOI
  82. Kargbo, 2023, Tryptamines and mental health: activating the 5-HT receptor for therapeutic potential, ACS Med. Chem. Lett., 14, 1331, 10.1021/acsmedchemlett.3c00390 · DOI
  83. Johnson, 2024, Alzheimer’s and metabolism wed with IDO1, Science, 385, 826, 10.1126/science.adr5836 · DOI
  84. Minhas, 2024, Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies, Science, 385, 10.1126/science.abm6131 · DOI · Paper page
  85. Knapskog, 2023, Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer’s disease, Alzheimer’s Dement., 19, 5573, 10.1002/alz.13162 · DOI
  86. Tafti, 2024, Mult. Scler.
  87. Nourbakhsh, 2018, Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course, Ann. Clin. Transl. Neurol., 5, 1211, 10.1002/acn3.637 · DOI
  88. Lim, 2017, Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression, Sci. Rep., 7
  89. Sundaram, 2014, Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies, J. Neuroinflamm., 11, 204, 10.1186/s12974-014-0204-5 · DOI · Paper page
  90. Dongol, 2023, Quinolinic acid impairs mitophagy promoting microglia senescence and poor healthspan in C. elegans: a mechanism of impaired aging process, Biol. Direct., 18, 86, 10.1186/s13062-023-00445-y · DOI
  91. Foster, 1984, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid, Neurosci. Lett., 48, 273, 10.1016/0304-3940(84)90050-8 · DOI · Paper page
  92. Fallarino, 2003, Modulation of tryptophan catabolism by regulatory T cells, Nat. Immunol., 4, 1206, 10.1038/ni1003 · DOI · Paper page
  93. Mezrich, 2010, An interaction between Kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells, J. Immunol., 185, 3190, 10.4049/jimmunol.0903670 · DOI · Paper page
  94. Pallotta, 2011, Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells, Nat. Immunol., 12, 870, 10.1038/ni.2077 · DOI · Paper page
  95. Van der Leek, 2017, The kynurenine pathway As a novel link between allergy and the gut microbiome, Front. Immunol., 8, 10.3389/fimmu.2017.01374 · DOI
  96. Mellor, 2004, Ido expression by dendritic cells: tolerance and tryptophan catabolism, Nat. Rev. Immunol., 4, 762, 10.1038/nri1457 · DOI · Paper page
  97. Xu, 2008, IDO: a double-edged sword for TH1/TH2 regulation, Immunol. Lett., 121, 1, 10.1016/j.imlet.2008.08.008 · DOI
  98. Esmaeili, 2022, The role of indoleamine 2,3-dioxygenase in allergic disorders, Mol. Biol. Rep., 49, 3297, 10.1007/s11033-021-07067-5 · DOI
  99. Wallet, 2005, Immunoregulation of dendritic cells, Clin. Med. Res., 3, 166, 10.3121/cmr.3.3.166 · DOI · Paper page
  100. H. Xu, T.B. Oriss, M. Fei, A.C. Henry, B.N. Melgert, L. Chen, A.L. Mellor, D.H. Munn, C.G. Irvin, P. Ray, A. Ray, Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation, 2008. www.pnas.org/cgi/content/full/. · DOI · Paper page
  101. Lau, 2021, Role of maternal tryptophan metabolism in allergic diseases in the offspring, Clin. Exp. Allergy, 51, 1346, 10.1111/cea.13953 · DOI
  102. Gostner, 2016, Tryptophan metabolism in allergic disorders, Int. Arch. Allergy Immunol., 169, 203, 10.1159/000445500 · DOI
  103. Liu, 2021, Role of tryptophan metabolism in cancers and therapeutic implications, Biochimie, 182, 131, 10.1016/j.biochi.2021.01.005 · DOI
  104. Peyraud, 2022, Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives, Front. Immunol., 13, 10.3389/fimmu.2022.807271 · DOI · Paper page
  105. van Baren, 2015, Tryptophan-degrading enzymes in tumoral immune resistance, Front. Immunol., 6, 10.3389/fimmu.2015.00034 · DOI · Paper page
  106. Hennequart, 2017, Constitutive IDO1 expression in Human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance, Cancer Immunol. Res., 5, 695, 10.1158/2326-6066.CIR-16-0400 · DOI · Paper page
  107. Zelenay, 2015, Cyclooxygenase-dependent tumor growth through evasion of immunity, Cell, 162, 1257, 10.1016/j.cell.2015.08.015 · DOI · Paper page
  108. Fiore, 2022, Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling, Mol. Cell, 82, 920, 10.1016/j.molcel.2022.02.007 · DOI · Paper page
  109. Bod, 2017, IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma, Oncoimmunology, 6, 1, 10.1080/2162402X.2016.1278331 · DOI
  110. Ramspott, 2018, Emerging role of IL-4–induced gene 1 as a prognostic biomarker affecting the local T-cell response in human cutaneous melanoma, J. Investig. Dermatol., 138, 2625, 10.1016/j.jid.2018.06.178 · doi:10.1016/j.jid.2018.06.178
  111. Sun, 2022, IL4I1 and tryptophan metabolites enhance AHR signals to facilitate colorectal cancer progression and immunosuppression, Am. J. Transl. Res., 14, 7758
  112. Balakrishna, 2021, Serotonin pathway in cancer, Int. J. Mol. Sci., 22, 1268, 10.3390/ijms22031268 · doi:10.3390/ijms22031268
  113. Dizeyi, 2011, Serotonin activates MAP kinase and PI3K/akt signaling pathways in prostate cancer cell lines, Urologic Oncol.: Semin. Original Investig., 29, 436, 10.1016/j.urolonc.2009.09.013 · DOI
  114. Zhu, 2022, 5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis, Neuron, 110, 2268, 10.1016/j.neuron.2022.04.024 · DOI
  115. Zakharia, 2021, Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma, J. Immunother. Cancer, 9, 10.1136/jitc-2020-002057 · DOI
  116. Forrest, 2013, Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway, Neuroscience, 254, 241, 10.1016/j.neuroscience.2013.09.034 · DOI · Paper page
  117. Hörsch, 2021, Long-term treatment with Telotristat Ethyl in patients with carcinoid syndrome symptoms: results from the TELEPATH study, Neuroendocrinology, 112, 298, 10.1159/000516958 · doi:10.1159/000516958
  118. Sarkar, 2004, Indole-3-carbinol and prostate cancer, J. Nutr., 134, 3493S, 10.1093/jn/134.12.3493S · DOI · Paper page
  119. Brown, 2011, The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome, Gastroenterology, 141, 507, 10.1053/j.gastro.2011.05.005 · DOI · Paper page
  120. Namkung, 2018, Inhibition of serotonin synthesis induces negative hepatic lipid balance, Diabetes Metab. J., 42, 233, 10.4093/dmj.2017.0084 · DOI

Metadata

Authors
Gabela, A. M., Mthembu, N., & Hadebe, S.
Venue
Immunology Letters
Publisher
Elsevier BV
Published
2026-02
Volume
277
Pages
107093
ISSN
0165-2478
Cited by
32
References
21
Language
en
Licence
Funders
  • South African Medical Research Council
  • University of Cape Town
  • National Research Foundation (138072)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tryptophan metabolism in health and disease- implications for non-communicable diseases. https://app.cochat.ai/papers/10.1016/j.imlet.2025.107093
The paper
Gabela, A. M., Mthembu, N., & Hadebe, S. (2026). Tryptophan metabolism in health and disease- implications for non-communicable diseases. Immunology Letters. https://doi.org/10.1016/j.imlet.2025.107093

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.